2026 NPPES data Allergy & Immunology Physician NPI 1164580866 M.D.
Verify on CMS →

MARK GRIJNSZTEIN, M.D.

Allergy & Immunology Physician in ELK GROVE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
845
Medicare Part D claims · 160 beneficiaries · Allergy & Immunology Physician avg: 764
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MARK GRIJNSZTEIN, M.D. filed 845 Medicare Part D claims in 2023 as a Allergy & Immunology Physician in ELK GROVE, California, prescribing 49% generic.

845
Part D claims, 2023
49%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK GRIJNSZTEIN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

845 Top 27% higher than 73% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MARK GRIJNSZTEIN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK GRIJNSZTEIN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 12/05/2006

NPI 1164580866

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

845 11% vs specialty avg

2023 prescription claims

Specialty avg: 764

Specialty distribution in California

How Allergy & Immunology Physician compares to other specialties among California providers

California providers

Allergy & Immunology Physician share within California

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Allergy & Immunology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Allergy & Immunology Physician ABMS/AOA estimate

Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK GRIJNSZTEIN, M.D. appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding M.D. credentials at 8170 LAGUNA BLVD, ELK GROVE, CA, 95758, with a listed phone of (916) 478-6555. NPI 1164580866 was issued on 12/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GRIJNSZTEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 845 prescription claims written by this provider, covering 160 Medicare beneficiaries and totaling roughly $540K in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8170 LAGUNA BLVD
ELK GROVE, CA 95758

Provider Details

NPI 1164580866
Specialty Allergy & Immunology Physician
Credentials M.D.
Gender Male
NPI Issued 12/05/2006

Hospital and facility affiliations

Facilities where MARK GRIJNSZTEIN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SUTTER VALLEY MEDICAL FOUNDATION
SACRAMENTO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARK GRIJNSZTEIN, M.D.. To verify MARK GRIJNSZTEIN, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MARK GRIJNSZTEIN, M.D. — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 845 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

845
Total Claims
$540K
Total Drug Cost
160
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,290
Total Day Supply
35,576
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$518K
Generic Drug Cost
$22K
Antibiotic Claims
16

Patient Demographics

Average Patient Age
70.9 years
Avg HCC Risk Score
0.92
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK GRIJNSZTEIN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ipratropium Bromide
113
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
69
Symbicort
Budesonide/Formoterol Fumarate
64
Albuterol Sulfate Hfa
Albuterol Sulfate
56
Dupixent Syringe
Dupilumab
46
Montelukast Sodium
45
Fluticasone Propionate
42
Spiriva Respimat
Tiotropium Bromide
34
Azelastine Hcl
32
Prednisone
30

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How MARK GRIJNSZTEIN, M.D. fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

MARK GRIJNSZTEIN, M.D.'s 845 claims are above the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GRIJNSZTEIN.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK GRIJNSZTEIN, M.D.'s specialty?
MARK GRIJNSZTEIN, M.D. specializes in Allergy & Immunology Physician and practices in ELK GROVE, California. Credentials: M.D..
How much does MARK GRIJNSZTEIN, M.D. prescribe under Medicare Part D?
In 2023, MARK GRIJNSZTEIN, M.D. wrote 845 Medicare Part D claims totaling $540K in drug costs for 160 beneficiaries.
Where is MARK GRIJNSZTEIN, M.D. located?
MARK GRIJNSZTEIN, M.D. is located at 8170 LAGUNA BLVD, ELK GROVE, CA, 95758. Phone: (916) 478-6555.
What is MARK GRIJNSZTEIN, M.D.'s NPI number?
MARK GRIJNSZTEIN, M.D.'s National Provider Identifier (NPI) is 1164580866, issued on 12/05/2006.
Does MARK GRIJNSZTEIN, M.D. prescribe more brand-name or generic drugs?
MARK GRIJNSZTEIN, M.D.'s prescribing is 51% brand-name and 49% generic drugs by claim count, with $518K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does MARK GRIJNSZTEIN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK GRIJNSZTEIN, M.D.'s most frequently prescribed drugs include Ipratropium Bromide, Trelegy Ellipta, Symbicort. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK GRIJNSZTEIN, M.D. accept Medicare?
MARK GRIJNSZTEIN, M.D. appears in CMS Medicare data with 845 Part D claims and 160 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK GRIJNSZTEIN, M.D.'s credentials?
MARK GRIJNSZTEIN, M.D.'s NPI is 1164580866 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology